FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Fate Therapeutics
Center for International Blood and Marrow Transplant Research
National Institutes of Health Clinical Center (CC)
AvenCell Therapeutics, Inc.
Allogene Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Essen Biotech
Center for International Blood and Marrow Transplant Research
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Weill Medical College of Cornell University
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Stanford University
Affiliated Hospital to Academy of Military Medical Sciences
Affiliated Hospital of Nantong University
Cedars-Sinai Medical Center
Celgene
Columbia University
Fate Therapeutics
Fate Therapeutics
Dartmouth-Hitchcock Medical Center
Bristol-Myers Squibb
Medical College of Wisconsin
St. Jude Children's Research Hospital
The Affiliated People's Hospital of Ningbo University
Loyola University
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
Icahn School of Medicine at Mount Sinai
University of Chicago
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
University of Pittsburgh
M.D. Anderson Cancer Center
Columbia University
University of Chicago
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
University of Illinois at Chicago
Weill Medical College of Cornell University